Skip to content
Home/Companies/Pharma/Catalent

Catalent

Pharma·United States·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Catalent?

Catalent is an American Pharma company, currently owned by Novo Holdings since 2024.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Novo Holdings
Investor
Novo Holdings
Novo Holdings Principal Investments · 1999 · Buyout

Key facts

HQUnited States
SectorPharma
StatusActive

More from Novo Holdings Principal Investments

Other portfolio companies in the same fund.

Tempus AI
Active
HealthTechUS· 2026
Benchmark Genetics
Active
AgTechUK· 2025
KalVista Pharmaceuticals
Active
PharmaUS· 2025
Schott Poonawalla
Active
IndustrialsIndia· 2025
Inozyme Pharma
Exited 2025
BiotechUS· 2023
to BioMarin Pharmaceutical
Manipal Hospitals
Active
HealthcareIndia· 2023

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Catalent?

Catalent is currently owned by Novo Holdings, through Novo Holdings Principal Investments, since 2024.

When did Novo Holdings acquire Catalent?

Novo Holdings acquired Catalent in 2024.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue